288 related articles for article (PubMed ID: 22954256)
1. Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles.
Tchou J; Kossenkov AV; Chang L; Satija C; Herlyn M; Showe LC; Puré E
BMC Med Genomics; 2012 Sep; 5():39. PubMed ID: 22954256
[TBL] [Abstract][Full Text] [Related]
2. MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.
Verghese ET; Drury R; Green CA; Holliday DL; Lu X; Nash C; Speirs V; Thorne JL; Thygesen HH; Zougman A; Hull MA; Hanby AM; Hughes TA
J Pathol; 2013 Nov; 231(3):388-99. PubMed ID: 23939832
[TBL] [Abstract][Full Text] [Related]
3. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
4. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
[TBL] [Abstract][Full Text] [Related]
5. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
[TBL] [Abstract][Full Text] [Related]
6. Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer.
Peng Q; Zhao L; Hou Y; Sun Y; Wang L; Luo H; Peng H; Liu M
PLoS One; 2013; 8(4):e60321. PubMed ID: 23577100
[TBL] [Abstract][Full Text] [Related]
7. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype.
Shah SH; Miller P; Garcia-Contreras M; Ao Z; Machlin L; Issa E; El-Ashry D
Cancer Biol Ther; 2015; 16(11):1671-81. PubMed ID: 26186233
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
12. ER-activating ability of breast cancer stromal fibroblasts is regulated independently of alteration of TP53 and PTEN tumor suppressor genes.
Suda T; Oba H; Takei H; Kurosumi M; Hayashi S; Yamaguchi Y
Biochem Biophys Res Commun; 2012 Nov; 428(2):259-63. PubMed ID: 23068099
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
14. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
Zhao L; Sun Y; Hou Y; Peng Q; Wang L; Luo H; Tang X; Zeng Z; Liu M
Int J Biochem Cell Biol; 2012 Nov; 44(11):2051-9. PubMed ID: 22964023
[TBL] [Abstract][Full Text] [Related]
15. Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs).
Rong G; Kang H; Wang Y; Hai T; Sun H
PLoS One; 2013; 8(8):e70960. PubMed ID: 23951052
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
[TBL] [Abstract][Full Text] [Related]
17. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.
Bottai G; Diao L; Baggerly KA; Paladini L; Győrffy B; Raschioni C; Pusztai L; Calin GA; Santarpia L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106823
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
Cid S; Eiro N; Fernández B; Sánchez R; Andicoechea A; Fernández-Muñiz PI; González LO; Vizoso FJ
Clin Breast Cancer; 2018 Feb; 18(1):e123-e133. PubMed ID: 28927692
[TBL] [Abstract][Full Text] [Related]
20. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
